Author: Shawn Jain


Novel Grant Opportunity Focused on the Science of the Patient Announced with AACR

PHILADELPHIA — The American Association for Cancer Research (AACR) announced today a new partnership with The Mark Foundation for Cancer Research to support innovative research focused on understanding the influence of the biology of the patient on the genesis, development, treatment, and survivorship of cancer. “We are excited to partner with The Mark Foundation in … Continued

A Note on COVID-19/Novel Coronavirus

April 17 update to our grantees: We have been monitoring the COVID-19 situation and the impacts of lab closures on wet lab research activities. To ensure that each of our grantees receives the appropriate funds needed at this time, we will be reaching out directly to any grantees who are scheduled for grant payments in … Continued

Partnership with Chordoma Foundation Announced to Fund Open-Source Research to Accelerate Drug Discovery

NEW YORK, NY – The Chordoma Foundation (CF) and The Mark Foundation for Cancer Research (MFCR) announced today a two-year, $1.4M partnership with a team of researchers at three institutions to develop new treatments for chordoma, a rare and difficult-to-treat bone cancer. The researchers will focus on creating the first drugs to inhibit a protein … Continued

New Cancer Center Established at Johns Hopkins University

With $5 million award, The Mark Foundation for Cancer Research partners with multi-investigator team at Johns Hopkins University developing next-generation genomics and imaging platforms for cancer immunotherapy NEW YORK, NY — The Mark Foundation for Cancer Research announced today the creation of The Mark Foundation Center for Advanced Genomics and Imaging at the Johns Hopkins … Continued

2020 Emerging Leader Awards Announced

$4.5 million awarded to six outstanding early career scientists to support innovation in cancer research The Mark Foundation for Cancer Research (MFCR) has awarded six grants to promising early career scientists for projects aimed at addressing unmet needs in cancer research. The Emerging Leader Award program aims to empower early career investigators to take on … Continued

$2.5 Million to JAX for Breakthrough Cancer Immunotherapy Project

$2.3M over five years

Four Projects Funded That Will Pave the Way For Novel Anti-Cancer Therapies

$12M AWARED TO STUDY RADIATION THERAPY AND IMMUNE SIGNALING

With Additions, Commitment Bolstered to Investing in Innovation

Anna Turetsky joins as Venture Investments Principal and Paul Pospisil joins Board The Mark Foundation for Cancer Research (MFCR) announced today the appointment of Anna Turetsky, PhD as Principal, Venture Investments. Turetsky joins MFCR with 10 years of experience in scientific research, consulting, and venture capital. She will work with MFCR’s executive and scientific leadership … Continued

Funding Announced for Eight Projects at the Intersection of Artificial Intelligence and Cancer Research

$2.2 million awarded to harness revolutions in machine learning for cancer research Can 3D renderings of pancreatic cancer tumors provide insights that improve the prognosis for one of the deadliest cancer types? Can machine learning help us better predict which patients will benefit from immunotherapies, which currently have a 30-50 percent success rate? And can … Continued

Funding Announced for the EXTOL Project

Expanding Therapeutic Options for Lung Cancer Patients The Mark Foundation for Cancer Research funds research in memory of personalized medicine pioneer Dr. Waun Ki Hong The Mark Foundation has awarded a three-year $6 million grant to support a new phase of discovery for a team of investigators developing, optimizing, and integrating targeted therapies and immunotherapies … Continued